Leveraging Epigenomics to Accelerate Chromatin Research and Drug Discovery | AACR

Leveraging generative AI to accelerate drug discovery and developmentПодробнее

Leveraging generative AI to accelerate drug discoveryПодробнее

EpiCypher: Advancing Epigenomics for Drug DevelopmentПодробнее

MPG Primer: Regulatory Genomics and Epigenomics of Complex Traits (2014)Подробнее

BioHIT talk | Leveraging #bigdata & #AI for the transformation of cancer research and drug discoveryПодробнее

Discovering Smart Targets in Liver DiseaseПодробнее

Leveraging Expert- Curated Knowledge from COSMIC and QIAGEN to Avoid Pitfalls, Qualify Candidate...Подробнее

Accelerate research discovery and development with ON.MultiomicsПодробнее

How can AI help accelerate drug discovery?Подробнее

Major opportunity in AI-driven drug discoveryПодробнее

AI Drug Discovery: How Isomorphic Labs Will Cure Diseases FasterПодробнее

Ontario Institute for Cancer Research, Drug Discovery ProgramПодробнее

Combining CRISPR and AI to accelerate cancer drug discoveryПодробнее

Targeting DNA Methylation and Chromatin for Cancer TherapyПодробнее

Technical Deep Dive: Understanding the KRAS Services Platform in RAS AssaysПодробнее

How Bioinformatics and AI Transforming Drug Discovery globallyПодробнее

AACR Special Conference on Chromatin and Epigenetics in CancerПодробнее